These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16462766)

  • 21. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
    Jungert K; Buck A; Buchholz M; Wagner M; Adler G; Gress TM; Ellenrieder V
    Carcinogenesis; 2006 Dec; 27(12):2392-401. PubMed ID: 16714330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emodin negatively affects the phosphoinositide 3-kinase/AKT signalling pathway: a study on its mechanism of action.
    Olsen BB; Bjørling-Poulsen M; Guerra B
    Int J Biochem Cell Biol; 2007; 39(1):227-37. PubMed ID: 17018259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway.
    Tang FY; Shih CJ; Cheng LH; Ho HJ; Chen HJ
    Mol Nutr Food Res; 2008 Jun; 52(6):646-54. PubMed ID: 18537129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway.
    Pang Y; Zheng B; Fan LW; Rhodes PG; Cai Z
    Glia; 2007 Aug; 55(11):1099-107. PubMed ID: 17577243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of c-myc protein in hormone refractory prostate carcinoma: cellular response to paclitaxel.
    Cassinelli G; Supino R; Zuco V; Lanzi C; Scovassi AI; Semple SC; Zunino F
    Biochem Pharmacol; 2004 Sep; 68(5):923-31. PubMed ID: 15294455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling.
    Li L; Wei XH; Pan YP; Li HC; Yang H; He QH; Pang Y; Shan Y; Xiong FX; Shao GZ; Zhou RL
    Oncogene; 2010 Oct; 29(43):5785-95. PubMed ID: 20711237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1(high) leukemia cells.
    Ichihara E; Kaneda K; Saito Y; Yamakawa N; Morishita K
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):239-45. PubMed ID: 22033412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrin-linked kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition.
    Lee YI; Kwon YJ; Joo CK
    Biochem Biophys Res Commun; 2004 Apr; 316(4):997-1001. PubMed ID: 15044083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of alpha5 integrin decreases PI3K activation and cell adhesion of human colon cancers.
    Murillo CA; Rychahou PG; Evers BM
    Surgery; 2004 Aug; 136(2):143-9. PubMed ID: 15300173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway.
    Bortul R; Tazzari PL; Billi AM; Tabellini G; Mantovani I; Cappellini A; Grafone T; Martinelli G; Conte R; Martelli AM
    Br J Haematol; 2005 Jun; 129(5):677-86. PubMed ID: 15916691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional upregulation and activation of p55Cdc via p34(cdc2) in Taxol-induced apoptosis.
    Makino K; Yu D; Hung MC
    Oncogene; 2001 May; 20(20):2537-43. PubMed ID: 11420663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [EVI1 and its role in myelodysplastic syndrome, myeloid leukemia and other malignant diseases].
    Fuchs O
    Cas Lek Cesk; 2006; 145(8):619-24. PubMed ID: 16995417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ecotropic viral integration site-1 is activated during, and is sufficient for, neuroectodermal P19 cell differentiation.
    Kazama H; Kodera T; Shimizu S; Mizoguchi H; Morishita K
    Cell Growth Differ; 1999 Aug; 10(8):565-73. PubMed ID: 10470856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance.
    Lim KH; Counter CM
    Cancer Cell; 2005 Nov; 8(5):381-92. PubMed ID: 16286246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EVI1 splice variants modulate functional responses in ovarian cancer cells.
    Dutta P; Bui T; Bauckman KA; Keyomarsi K; Mills GB; Nanjundan M
    Mol Oncol; 2013 Jun; 7(3):647-68. PubMed ID: 23517670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells.
    Luker KE; Pica CM; Schreiber RD; Piwnica-Worms D
    Cancer Res; 2001 Sep; 61(17):6540-7. PubMed ID: 11522652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation.
    McGilvray R; Walker M; Bartholomew C
    FEBS J; 2007 Aug; 274(15):3960-71. PubMed ID: 17635584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma.
    Yasui K; Konishi C; Gen Y; Endo M; Dohi O; Tomie A; Kitaichi T; Yamada N; Iwai N; Nishikawa T; Yamaguchi K; Moriguchi M; Sumida Y; Mitsuyoshi H; Tanaka S; Arii S; Itoh Y
    Cancer Sci; 2015 Jul; 106(7):929-37. PubMed ID: 25959919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of PI3K in PKCepsilon-mediated oncogenic signal in rat colonic epithelial cells.
    Marras E; Concari P; Cortellezzi L; Dondi D; De Eguileor M; Perletti G
    Int J Oncol; 2001 Aug; 19(2):395-9. PubMed ID: 11445858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.